- 专利标题: Cancer-killing cells
-
申请号: US16345366申请日: 2017-10-25
-
公开(公告)号: US11642373B2公开(公告)日: 2023-05-09
- 发明人: Alex Blyth , Nico Bruyniks
- 申请人: LIFT BIOSCIENCES LTD
- 申请人地址: GB Brighton
- 专利权人: LIfT Biosciences Ltd
- 当前专利权人: LIfT Biosciences Ltd
- 当前专利权人地址: GB Brighton
- 代理机构: Lee & Hayes PC
- 代理商 C. Rachal Winger; Chrystal Quisenberry
- 优先权: GB 18106 2016.10.26
- 国际申请: PCT/GB2017/053222 2017.10.25
- 国际公布: WO2018/078367A 2018.05.03
- 进入国家日期: 2019-04-26
- 主分类号: A61K35/15
- IPC分类号: A61K35/15 ; A61P35/00 ; A61K35/28 ; C12N5/0787 ; C12N5/0789 ; A61K31/198 ; A61K31/202 ; A61K31/375 ; A61K31/59 ; A61K38/19 ; A61K38/20 ; A61K38/27 ; G01N33/574
摘要:
The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
公开/授权文献
- US20190314409A1 CANCER-KILLING CELLS 公开/授权日:2019-10-17
信息查询
IPC分类: